Related Experiment Videos
Do immunoassays differentially detect different acidity glycoforms of FSH?
R L Oliver1, J W Kane, A Waite
1University of Manchester, UK.
Clinical Endocrinology
|January 5, 2000
Summary
Glycoprotein carbohydrate structures influence immunoassay recognition, but differences between FSH glycoforms were minor across three common assays. These variations are unlikely to impact clinical significance in routine testing.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Glycoprotein carbohydrate residues can affect recognition in immunoassays, a critical factor for accurate diagnostic testing.
- Understanding glycoform variability is essential for interpreting immunoassay results, particularly for hormones like follicle-stimulating hormone (FSH).
Purpose of the Study:
- To investigate the impact of varying isoelectric point (pI) on the recognition of follicle-stimulating hormone (FSH) glycoforms in routine immunoassays.
- To compare the performance of three different immunoassay platforms in recognizing FSH glycoform preparations.
Main Methods:
- Seven recombinant human FSH glycoform preparations with distinct pI values (3.8-5.5) were generated using isoelectric focusing.
- Molecular weights were confirmed by mass spectrometry, and glycoforms were assayed at known molarities in three different immunoassay formats.
- Results were analyzed relative to unfractionated FSH to identify differential recognition patterns.
Main Results:
- All three immunoassays (enzyme immunoassay, immunofluorometric assay, radioimmunoassay) showed largely consistent recognition of FSH glycoforms relative to a standard.
- Minor discrepancies were observed between assay pairs for glycoforms at the extreme ends of the pI range.
- Significant differences (up to 33%) in recognition were found within each assay type for different pI glycoforms, but without a clear trend across the acidity spectrum.
Conclusions:
- Few significant differences exist in FSH glycoform recognition across the investigated immunoassay methods when normalized to a common standard.
- While intra-assay differences in glycoform recognition were noted, they were generally small and unlikely to be clinically significant.
- The carbohydrate structure of FSH glycoforms has a limited impact on their recognition in routine immunoassays.